Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF100 Plus

Dosage form: lotion
Ingredients: Avobenzone 30mg in 1mL, Homosalate 150mg in 1mL, Octisalate 50mg in 1mL, Octocrylene 100mg in 1mL, Oxybenzone 60mg in 1mL
Labeler: Neutrogena Corporation
NDC Code: 10812-366

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF100+

Drug Facts

Active ingredients

Avobenzone 3%
Homosalate 15%
Octisalate 5%
Octocrylene 10%
Oxybenzone 6%

Purpose

Sunscreen

Uses
  • Helps prevent sunburn
  • (Optional) If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings
 
For external use only

 
Do not use on damaged or broken skin

 
When using this product keep out of eyes. Rinse with water to remove

 
Stop use and ask a doctor if rash occurs

 
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions
  • apply liberally 15 minutes before sun exposure
  • reapply:
    • after 40 minutes [or 80 minutes] of swimming or sweating
    • immediately after towel drying
    • at least every 2 hours
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum value of SPF of 15 or higher and other sun protection measures including:
    • Limit time in the sun, especially from 10 a.m. – 2 p.m.
    • Wear long-sleeved shirts, pants hats, and sunglasses
  • Children under 6 months: Ask a doctor

Other information
  • Protect this product from excessive heat and direct sun
  • May stain some fabrics

Inactive ingredients

Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Acrylates/Dimethicone Copolymer, Beeswax, BHT, Chlorphenesin, Cyclopentasiloxane, Diethylhexyl 2,6-Naphthalate, Dipotassium Glycyrrhizate, Disodium EDTA, Ethylhexylglycerin, Fragrance, Glyceryl Stearate, Methylisothiazolinone, PEG-100 Stearate, Silica, Styrene/Acrylates Copolymer, Triethanolamine, Water

Questions or comments?

Call toll-free 800-299-4786 or 215-273-8755 (collect) or visit www.neutrogena.com

Dist. by Neutrogena Corp., Los Angeles, CA 90045

PRINCIPAL DISPLAY PANEL - 88 mL Tube Label

Neutrogena®

Ultra Sheer
DRY-TOUCH
SUNSCREEN

Broad Spectrum
SPF 100+

helioplex®
broad spectrum uva-uvb

RECOMMENDED
SKIN
CANCER
FOUNDATION
RECOMMENDED
AS AN EFFECTIVE
UF SUNSCREEN

LIGHTWEIGHT
CLEAN FEEL
fast absorbing
water resistant
(80 minutes)

#1 DERMATOLOGIST
RECOMMENDED SUNCARE

3.0 FL OZ (88mL)

NEUTROGENA ULTRA SHEER DRY TOUCH   SUNSCREEN BROAD SPECTRUM SPF100 PLUS
avobenzone, homosalate, octisalate, octocrylene, and oxybenzone lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10812-366
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Avobenzone (Avobenzone) Avobenzone30 mg  in 1 mL
Homosalate (Homosalate) Homosalate150 mg  in 1 mL
Octisalate (Octisalate) Octisalate50 mg  in 1 mL
Octocrylene (Octocrylene) Octocrylene100 mg  in 1 mL
Oxybenzone (Oxybenzone) Oxybenzone60 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
Yellow Wax 
Butylated Hydroxytoluene 
Chlorphenesin 
Cyclomethicone 5 
Diethylhexyl 2,6-Naphthalate 
Glycyrrhizinate Dipotassium 
Edetate Disodium 
Ethylhexylglycerin 
Glyceryl Monostearate 
Methylisothiazolinone 
PEG-100 Stearate 
Silicon Dioxide 
Trolamine 
Water 
Packaging
#Item CodePackage Description
1NDC:10812-366-0188 mL in 1 TUBE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35204/01/2010
Labeler - Neutrogena Corporation (008254617)
Registrant - Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc. (830803164)

Revised: 07/2013
 
Neutrogena Corporation

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web1)